| Identification | Back Directory | [Name]
2,4(1H,3H)-Pyrimidinedione, 1-(5-deoxy-β-D-ribo-hexofuranosyl)- | [CAS]
30685-57-5 | [Synonyms]
Homouridine 1-(5-Deoxy-β-D-ribo-hexofuranosyl)-2,4(1H,3H)-pyrimidinedione 2,4(1H,3H)-Pyrimidinedione, 1-(5-deoxy-β-D-ribo-hexofuranosyl)- | [Molecular Formula]
C10H14N2O6 | [MOL File]
30685-57-5.mol | [Molecular Weight]
258.23 |
| Hazard Information | Back Directory | [Uses]
Homouridine, is an uridine analogue. Homouridine serves as an intermediate to prepare MMP-2 inhibitor (compund I, IC50=150 μM). Homouridine derivate (compund I) also inhibits TNF-α binding to TNF-αR1[1]. | [References]
[1] Hsu Li-Wei, et al. Uridine derivatives as matrix metalloproteinase (MMP) and tumor necrosis factor (TNF) inhibitors for the treatment of cancer. European Patent Organization, EP1338282 A1. 2003-08-27. |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-571-86912261 19975279805 |
| Website: |
https://www.newcanbio.com/ |
|